Becton Dickinson, BioMedomics Collaborate On Rapid Serology COVID-19 Test

BD and BioMedomics will soon begin distributing a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.

BERLIN, GERMANY - June 06, 2016: BD Vacutainer blood collection tubes
• Source: shutterstock.com

[Editor’s note: This article was updated on 7 April to clarify the regulatory status of the Becton Dickinson/BioMedomics serology COVID-19 test and update the status of the BioGx's rapid COVID-19 test, which runs on Becton Dickinson's automated system.]

Becton Dickinson & Co

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Approvals

More from Policy & Regulation